Follow
anna artese
anna artese
Dipartimento di Scienze della Salute, Universitą degli Studi Magna Graecia di Catanzaro
Verified email at unicz.it
Title
Cited by
Cited by
Year
Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations
F Moraca, J Amato, F Ortuso, A Artese, B Pagano, E Novellino, S Alcaro, ...
Proceedings of the National Academy of Sciences 114 (11), E2136-E2145, 2017
1092017
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors
V Cento, C Mirabelli, R Salpini, S Dimonte, A Artese, G Costa, F Mercurio, ...
PloS one 7 (7), e39652, 2012
1092012
Hybrid ligand–alkylating agents targeting telomeric G-quadruplex structures
F Doria, M Nadai, M Folini, M Di Antonio, L Germani, C Percivalle, C Sissi, ...
Organic & biomolecular chemistry 10 (14), 2798-2806, 2012
1012012
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
A Artese, V Svicher, G Costa, R Salpini, VC Di Maio, M Alkhatib, ...
Drug Resistance Updates 53, 100721, 2020
962020
Identification and characterization of new DNA G-quadruplex binders selected by a combination of ligand and structure-based virtual screening approaches
S Alcaro, C Musetti, S Distinto, M Casatti, G Zagotto, A Artese, L Parrotta, ...
Journal of medicinal chemistry 56 (3), 843-855, 2013
952013
New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors
I Malet, L Gimferrer Arriaga, A Artese, G Costa, L Parrotta, S Alcaro, ...
Journal of Antimicrobial Chemotherapy 69 (8), 2118-2122, 2014
852014
Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to …
F Ceccherini-Silberstein, V Svicher, T Sing, A Artese, MM Santoro, ...
Journal of virology 81 (20), 11507-11519, 2007
832007
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome
D Bagetta, A Maruca, A Lupia, F Mesiti, R Catalano, I Romeo, F Moraca, ...
European journal of medicinal chemistry 186, 111903, 2020
772020
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile
A Maruca, R Catalano, D Bagetta, F Mesiti, FA Ambrosio, I Romeo, ...
European journal of medicinal chemistry 181, 111579, 2019
722019
Hepatitis C virus genetic variability and the presence of NS5B resistance-associated mutations as natural polymorphisms in selected genotypes could affect the response to NS5B …
VC Di Maio, V Cento, C Mirabelli, A Artese, G Costa, S Alcaro, CF Perno, ...
Antimicrobial agents and chemotherapy 58 (5), 2781-2797, 2014
682014
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors
F Ceccherini-Silberstein, I Malet, L Fabeni, S Dimonte, V Svicher, ...
Journal of antimicrobial chemotherapy 65 (11), 2305-2318, 2010
632010
SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation
L D''antona, R Amato, C Talarico, F Ortuso, M Menniti, V Dattilo, R Iuliano, ...
Cellular physiology and biochemistry 35 (5), 2006-2018, 2015
612015
Kaempferol as selective human MAO-A inhibitor: analytical detection in calabrian red wines, biological and molecular modeling studies
MC Gidaro, C Astorino, A Petzer, S Carradori, F Alcaro, G Costa, A Artese, ...
Journal of agricultural and food chemistry 64 (6), 1394-1400, 2016
602016
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase
R Meleddu, S Distinto, A Corona, G Bianco, V Cannas, F Esposito, ...
European journal of medicinal chemistry 93, 452-460, 2015
582015
Molecular interaction fields in drug discovery: recent advances and future perspectives
A Artese, S Cross, G Costa, S Distinto, L Parrotta, S Alcaro, F Ortuso, ...
Wiley Interdisciplinary Reviews: Computational Molecular Science 3 (6), 594-613, 2013
532013
SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021
M Alkhatib, V Svicher, R Salpini, FA Ambrosio, MC Bellocchi, L Carioti, ...
Microbiology spectrum 9 (3), e01096-21, 2021
512021
Update on SARS-CoV-2 omicron variant of concern and its peculiar mutational profile
M Alkhatib, R Salpini, L Carioti, FA Ambrosio, S D’Anna, L Duca, G Costa, ...
Microbiology spectrum 10 (2), e02732-21, 2022
452022
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens
V Svicher, C Alteri, A Artese, F Forbici, MM Santoro, D Schols, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (3), 336-344, 2010
452010
Aryl ethynyl anthraquinones: a useful platform for targeting telomeric G-quadruplex structures
C Percivalle, C Sissi, ML Greco, C Musetti, A Mariani, A Artese, G Costa, ...
Organic & biomolecular chemistry 12 (22), 3744-3754, 2014
442014
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold
F Ortuso, R Amato, A Artese, L D’antona, G Costa, C Talarico, F Gigliotti, ...
Journal of chemical information and modeling 54 (7), 1828-1832, 2014
432014
The system can't perform the operation now. Try again later.
Articles 1–20